Close
Close
Treatment Database
2-[3-(2-chloro-4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)-1,2-oxazol-4-yl]methoxy}phenyl)-3-hydroxyazetidin-1-yl]pyridine-4-carboxylic acid-2-amino-2-(hydroxymethyl)propane-1,3-diol (1/1)
Trade Name not avaiable
Orphan Indication Primary sclerosing cholangitis
EU Market Approval
EU Designation Date 01-04-2019
Sponsor Gilead Sciences Ireland UC
More about Primary sclerosing cholangitis
Free Newsletter
Videos
by Abidemi Uruejoma
6 views
by Abidemi Uruejoma
3 views
by Abidemi Uruejoma
17 views